Shuming Yin
Shanghai Key Laboratory Of Regulatory Biology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Author Correction: Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain.
Journal: Nature cell biology
Published: June 17, 2026
Engineered Un1Cas12f1 for multiplex genome editing with enhanced activity and targeting scope.
Journal: Nature communications
Published: August 15, 2025
LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.
Journal: Clinical and translational medicine
Published: July 18, 2025
Real-world study on efficacy and safety of pancreatin enteric-coated capsules in treatment of postprandial distress syndrome in older patients.
Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
Published: July 17, 2025
Construction of pathogenic Sec16a mutation mouse model using CRISPR/Cas9.
Journal: Animal models and experimental medicine
Published: November 22, 2024
Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo.
Journal: Nature biotechnology
Published: August 28, 2024
Corrigendum to "Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration" [Journal of Genetics and Genomics (2022) 49, 1114-1126].
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: June 09, 2024
Amelioration of metabolic and behavioral defects through base editing in the PahR408W phenylketonuria mouse model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 21, 2024
Lipid nanoparticle-mediated base-editing of the Hao1 gene achieves sustainable primary hyperoxaluria type 1 therapy in rats.
Journal: Science China. Life sciences
Published: March 20, 2024
Engineering APOBEC3A deaminase for highly accurate and efficient base editing.
Journal: Nature chemical biology
Published: May 16, 2023
A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing.
Journal: Cellular & molecular immunology
Published: March 14, 2023
Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 10, 2022
Last Updated: 09/26/2026